Having first achieved FDA approval in 2019, Oculogica’s EyeBOX remains the “only FDA-cleared and Health Canada registered diagnostic aid for concussion that does not require a pre-injury baseline test.” The new FDA label allows providers to use the EyeBOX to monitor a patient’s recovery over time by comparing the patient’s recovery to normative data.